RYBP Expression Is Regulated by KLF4 and Sp1 and Is Related to Hepatocellular Carcinoma Prognosis

Qiaojiajie Zhao1, Weihua Cai2, Xuan Zhang1

  • 1From the State Key Laboratory of Medical Molecular Biology, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, 5 Dong Dan San Tiao, Beijing 100005, China.

Insights

Reduced Ring1- and YY1-binding protein (RYBP) in hepatocellular carcinoma (HCC) is linked to KLF4 and Sp1 transcription factors. Altered expression of these factors and RYBP correlates with poorer HCC prognosis and metastasis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Ring1- and YY1-binding protein (RYBP) expression is decreased in human cancers, but the underlying mechanisms are unclear.
  • Hepatocellular carcinoma (HCC) is a major global health concern with complex molecular underpinnings.
  • Understanding the regulation of RYBP is crucial for developing novel cancer therapies and biomarkers.

Purpose of the Study:

  • To elucidate the molecular mechanisms regulating RYBP expression in HCC.
  • To identify transcription factors involved in RYBP dysregulation in HCC.
  • To investigate the correlation between RYBP, KLF4, Sp1, and HCC patient prognosis.

Main Methods:

  • Cloning and characterization of the human RYBP gene promoter region.
  • Analysis of promoter sequence variation and CpG methylation in HCC tissues.
  • Identification and mapping of transcription factor binding sites (KLF4 and Sp1) on the RYBP promoter.
  • In vitro studies on HCC cell growth modulation by KLF4 and Sp1.
  • Correlation analysis of RYBP, KLF4, and Sp1 expression with clinical parameters in HCC patient specimens.

Main Results:

  • Decreased RYBP expression in HCC is not due to promoter mutations or methylation.
  • KLF4 suppresses and Sp1 promotes RYBP transcription by binding to its promoter.
  • KLF4 inhibits and Sp1 promotes HCC cell growth via RYBP modulation.
  • Deregulated KLF4 and Sp1 contribute to reduced RYBP levels in HCC tumors.
  • Lower RYBP levels, associated with altered KLF4/Sp1, correlate with larger tumor size, poorer differentiation, and increased metastasis.

Conclusions:

  • KLF4 and Sp1 are key regulators of RYBP expression in HCC.
  • Dysregulation of KLF4, Sp1, and RYBP is associated with poor HCC prognosis and metastasis.
  • RYBP may serve as a potential therapeutic target and prognostic biomarker for HCC, possibly in combination with KLF4 and Sp1.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.8K
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K